BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 16284611)

  • 1. Purging of murine erythroblastic leukemia by ZnPcS2P2-based-photodynamic therapy.
    Huang HF; Chen YZ; Wu Y; Chen P
    Bone Marrow Transplant; 2006 Jan; 37(2):213-7. PubMed ID: 16284611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental studies of the effects of ZnPcS2P2-based-photodynamic therapy on bone marrow purging.
    Huang HF; Chen YZ; Wu Y
    Chin Med J (Engl); 2005 Jan; 118(2):105-10. PubMed ID: 15667794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of zinc phthalocyanine-mediated photodynamic therapy on bone marrow purging, an experimental study].
    Huang HF; Chen YZ; Wu Y
    Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):986-91. PubMed ID: 12899802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purging efficacy of ZnPcH₁-based photodynamic therapy on chronic myeloid leukemia bone marrow.
    Huang H; Chen Y; Chen W; Wu Y
    Int J Lab Hematol; 2011 Oct; 33(5):477-82. PubMed ID: 21457188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of etoposide in combination with cyclosporin for purging multidrug-resistant leukemic cells from bone marrow in a mouse model.
    Kühl JS; Sikic BI; Blume KG; Chao NJ
    Exp Hematol; 1992 Oct; 20(9):1048-54. PubMed ID: 1468539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of photodynamic therapy for elimination of residual leukemic cells in autologous transplants of hematopoietic progenitor cells].
    Hrkal Z; Grebenová D; Cajthamlová H; Soucek J; Bartosová J; Fuchs O; Marinov I; Kobylka P; Klamová H; Sponerová D
    Cas Lek Cesk; 2002 Sep; 141 Suppl():41-6. PubMed ID: 12428422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of cytoprotective mechanisms in the photochemical purging of autologous bone marrow grafts.
    Yamazaki T; Sato Y; Sieber F
    Exp Hematol; 1997 Jul; 25(7):629-37. PubMed ID: 9216739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purging of leukemia-contaminated bone marrow grafts using suicide adenoviral vectors: an in vivo murine experimental model.
    Garcia-Castro J; Rio P; Lillo R; Garcia-Sanchez F; Segovia JC; Bueren JA
    Gene Ther; 2003 Aug; 10(16):1328-35. PubMed ID: 12883529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purging leukemia remission marrows with alkyl-lysophospholipids, preclinical and clinical results.
    Vogler WR; Olson AC; Berdel WE; Okamoto S; Glasser L
    Prog Clin Biol Res; 1990; 333():1-18; discussion 19-20. PubMed ID: 2308973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Establishment and application of a murine transplant model of bone marrow purging of metastatic breast cancer cells in vitro].
    Hu ZP; Liu WL; Stuart B; Zhang YC
    Zhonghua Xue Ye Xue Za Zhi; 2007 Sep; 28(9):621-3. PubMed ID: 18246821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination and pharmacokinetics of photosensitizer ZnPcS2P2 uptaken by K562 cells].
    Xie BG; Huang HF; Huang JD; Chen NS; Huang JL
    Guang Pu Xue Yu Guang Pu Fen Xi; 2004 Nov; 24(11):1415-8. PubMed ID: 15762492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The alkyl-lysophospholipid, ET-18-OCH3 synergistically enhances the Merocyanine 540-mediated photoinactivation of leukemia cells: implications for the extracorporeal purging of autologous hematopoietic stem cells.
    Yamazaki T; Sieber F
    Bone Marrow Transplant; 1997 Jan; 19(2):113-9. PubMed ID: 9116607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Selective photodynamic destruction of leukemic cells].
    Hrkal Z; Cajthamlová H; Grebenová D; Bartosová J; Klamová H; Marinov J
    Cas Lek Cesk; 2000 Mar; 139(5):148-54. PubMed ID: 10838736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential killing of murine B-cell leukemia (BCL1) by photosensitization with merocyanine 540: implications for autologous bone marrow transplantation.
    Mumcuoglu M; Weiss L; Spivak J; Slavin S
    Bone Marrow Transplant; 1989 Mar; 4(2):143-6. PubMed ID: 2650782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Leukemia SH-1 cells purged by ZnPcH(1)-based photodynamic therapy].
    Lin XL; Huang HF; Chen WZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):842-6. PubMed ID: 22931639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and toxicity of 9-beta-D-arabinofuranosylguanine (araG) as an agent to purge malignant T cells from murine bone marrow: application to an in vivo T-leukemia model.
    Gravatt LC; Chaffee S; Hebert ME; Halperin EC; Friedman HS; Kurtzberg J
    Leukemia; 1993 Aug; 7(8):1261-7. PubMed ID: 8350627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient and nontoxic adenoviral purging method for autologous transplantation in breast cancer patients.
    Lillo R; Ramírez M; Alvarez A; Santos S; García-Castro J; Fernández de Velasco J; Avilés MJ; Gómez-Pineda A; Díez JL; Balas A; Vicario JL; Bueren JA; García-Sánchez F
    Cancer Res; 2002 Sep; 62(17):5013-8. PubMed ID: 12208755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hexaminolevulinate-mediated photodynamic purging of marrow grafts with murine breast carcinoma.
    Čunderlíková B; Vasovič V; Sieber F; Furre T; Borgen E; Nesland JM; Peng Q
    Bone Marrow Transplant; 2011 Aug; 46(8):1118-27. PubMed ID: 21057550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term regression of the murine mammary adenocarcinoma, LM3, by repeated photodynamic treatments using meso-tetra (4-N-methylpyridinium) porphine.
    Colombo LL; Vanzulli SI; Villanueva A; Cañete M; Juarranz A; Stockert JC
    Int J Oncol; 2005 Oct; 27(4):1053-9. PubMed ID: 16142323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell cycle-based purging of lymphoma cells from bone marrow harvests using radioiodinated 5-iodo-2'-deoxyuridine.
    Schneiderman MH; Jackson JD; Joshi SS; Clark-Pierce L; Murphy BJ; Schneiderman GS
    Radiat Res; 1998 Feb; 149(2):147-54. PubMed ID: 9457894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.